Denmark: IO Biotech raises US$100m to advance development of lead
IO Biotech, headquartered in Denmark, priced the IPO of 7,150,000 shares of its common stock at a US$14.00 per share on Nasdaq, to raise...
Germany: Evotec raises US$435m from ADS offering on Nasdaq
Evotec, a drug discovery and development company headquartered in Hamburg, Germany, has raised US$435m from a Nasdaq cross-listing. The deal was downsized from an...
Israel: Teva Pharmaceutical prices upsized US$5bn sustainability-linked notes
Teva Pharmaceutical upsized and priced approximately US$5bn of its debut sustainability-linked senior notes (SLN). The offering amount of the offering was increased from the...
Sweden: ADDvise places Skr250m bond to finance future acquisitions
ADDvise Group, a supplier of equipment to healthcare and research facilities, has placed a Skr250m (US$29.3m) senior secured bond issue under its existing bond...
Switzerland: Skan prices IPO at Sfr54 per share raising gross proceeds of Sfr93.5m
Skan, a Swiss company and market and technological leader for isolators, cleanroom devices, and decontamination processes for the aseptic production of biopharmaceutical substances, priced...
Israel: Teva Pharma plans US$4bn sustainability-linked notes to buy back notes due 2022 –...
Teva Pharmaceutical Industries has issued US$4bn of dual-currency sustainability-linked senior notes. The generic drug maker will use the proceeds, along with cash in hand,...
Aedifica establishes UK team with acquisition of Layland Walker
Belgian healthcare REIT Aedifica has expanded its presence in the UK with the acquisition of its asset management partner Layland Walker.
Layland Walker was established...
IFC with first Social SOFR FRN to improve lives in developing countries
IFC has issued a new US$500m short 2-1/2-year social Floating Rate Note (FRN) with proceeds targeted to improve the lives of the most vulnerable...
Netherlands: Onward Medical prices IPO at €12.75
Netherlands-headquartered Onward Medical, a medical technology company developing and commercialising therapies to enable functional recovery for people with spinal cord injury, has priced its...
China: LianBio files for proposed IPO of ADS in US
LianBio, a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, has announced the launch of its...
©2021 All rights reserved LaingBuisson 
